Guoxiong Xu (Lingyun Zhang)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Venues

Apoptosis : an international journal on programmed cell death

Current medicinal chemistry

The Journal of international medical research

Molecular oncology

JInshan Hospital of Fudan University

York University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

JInshan Hospital of Fudan University

China

Professor/Dr./Director :: Research Center for Clinical Medicine

Education History

York University

Canada

PHD :: Biology

Publications

Xin Li, Wencai Guan, Huiqiang Liu, Jia Yuan, Fanchen Wang, Bin Guan, Junyu Chen, Qi Lu, Guoxiong Xu, Guoxiong Xu
Correction: Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer. Apoptosis : an international journal on programmed cell death (2024)
Xin Li, Huiqiang Liu, Fanchen Wang, Jia Yuan, Wencai Guan, Guoxiong Xu
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs. Current medicinal chemistry 31 (26) (2024)
Danjuan Ye, Xiaoling Duan, Bin Guan, Jia Yuan, Yan Zhu, Jimin Shi, Qi Lu, Guoxiong Xu
Biomarker cystatin B expression correlates with pathogenesis in cervical cancer. The Journal of international medical research 52 (3) (2024)
Xin Li, Huiqiang Liu, Fanchen Wang, Jia Yuan, Wencai Guan, Guoxiong Xu
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs. Current medicinal chemistry 31 (26) (2024)
Danjuan Ye, Xiaoling Duan, Bin Guan, Jia Yuan, Yan Zhu, Jimin Shi, Qi Lu, Guoxiong Xu
Biomarker cystatin B expression correlates with pathogenesis in cervical cancer. The Journal of international medical research 52 (3) (2024)
Danjuan Ye, Xiaoling Duan, Bin Guan, Jia Yuan, Yan Zhu, Jimin Shi, Qi Lu, Guoxiong Xu
Biomarker cystatin B expression correlates with pathogenesis in cervical cancer. The Journal of international medical research 52 (3) (2024)
Xin Li, Wencai Guan, Huiqiang Liu, Jia Yuan, Fanchen Wang, Bin Guan, Junyu Chen, Qi Lu, Guoxiong Xu, Guoxiong Xu
Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer. Apoptosis : an international journal on programmed cell death (2024)
Xin Li, Huiqiang Liu, Fanchen Wang, Jia Yuan, Wencai Guan, Guoxiong Xu
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients Using Paclitaxel-Resistant Immune-Related lncRNAs. Current medicinal chemistry (2024)
Xin Li, Wencai Guan, Huiqiang Liu, Jia Yuan, Fanchen Wang, Bin Guan, Junyu Chen, Qi Lu, Guoxiong Xu, Guoxiong Xu
Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer. Apoptosis : an international journal on programmed cell death (2024)
Xiaoling Duan, Danjuan Ye, Jia Yuan, Bin Guan, Wencai Guan, Songping Liu, Jingyi Fang, Jimin Shi, Yan Zhu, Qinmei Li, Qi Lu, Guoxiong Xu
COL5A1 overexpression correlates with poor prognosis in human cervical cancer. The International journal of biological markers (2024)
Danjuan Ye, Xiaoling Duan, Bin Guan, Jia Yuan, Yan Zhu, Jimin Shi, Qi Lu, Guoxiong Xu
Biomarker cystatin B expression correlates with pathogenesis in cervical cancer. The Journal of international medical research 52 (3) (2024)
Xin Li, Huiqiang Liu, Fanchen Wang, Jia Yuan, Wencai Guan, Guoxiong Xu
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs. Current medicinal chemistry 31 (26) (2024)
Xin Li, Wencai Guan, Huiqiang Liu, Jia Yuan, Fanchen Wang, Bin Guan, Junyu Chen, Qi Lu, Guoxiong Xu, Guoxiong Xu
Correction: Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer. Apoptosis : an international journal on programmed cell death (2024)
Xin Li, Wencai Guan, Huiqiang Liu, Jia Yuan, Fanchen Wang, Bin Guan, Junyu Chen, Qi Lu, Guoxiong Xu, Guoxiong Xu
Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer. Apoptosis : an international journal on programmed cell death (2024)
Jia Yuan, Xin Li, Fanchen Wang, Huiqiang Liu, Wencai Guan, Guoxiong Xu
Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer. Experimental biology and medicine (Maywood, N.J.) (2023)
Fanchen Wang, Xiaolin Xu, Xin Li, Jia Yuan, Xuzhu Gao, Chenglong Wang, Wencai Guan, Guoxiong Xu
Target Finder of Transcription Factor (TFoTF): a novel tool to predict transcription factor-targeted genes in cancer. Molecular oncology (2023)
Fanchen Wang, Xiaolin Xu, Xin Li, Jia Yuan, Xuzhu Gao, Chenglong Wang, Wencai Guan, Guoxiong Xu
Target Finder of Transcription Factor (TFoTF): a novel tool to predict transcription factor-targeted genes in cancer. Molecular oncology (2023)
Chenglong Wang, Xiaolin Xu, Peipei Zhang, Shuhan Xiong, Jia Yuan, Xuzhu Gao, Wencai Guan, Fanchen Wang, Xin Li, Hongjing Dou, Guoxiong Xu
Lipid-coated albumin-paclitaxel nanoparticles loaded with sorcin-siRNA reverse cancer chemoresistance via restoring intracellular calcium ion homeostasis. Journal of nanobiotechnology 20 (1) (2022)
Fan Chao, Zhenyu Song, Shiyu Wang, Zhe Ma, Zhiyuan Zhuo, Ting Meng, Guoxiong Xu, Gang Chen
Novel circular RNA circSOBP governs amoeboid migration through the regulation of the miR-141-3p/MYPT1/p-MLC2 axis in prostate cancer. Clinical and translational medicine 11 (3) (2022)
Shiyu Wang, Guoxiong Xu, Fan Chao, Cong Zhang, Dunsheng Han, Gang Chen
HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer. Cancer management and research 13 (2021)
Jinguo Zhang, Wencai Guan, Xiaolin Xu, Fanchen Wang, Xin Li, Guoxiong Xu
A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer. Oncogene 40 (30) (2021)
Jinguo Zhang, Jihong Zhang, Fanchen Wang, Xiaolin Xu, Xin Li, Wencai Guan, Ting Men, Guoxiong Xu
Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor-infiltrating immune cells in ovarian cancer. Journal of cellular physiology 236 (10) (2021)
Xiaoqun Lv, Jinguo Zhang, Jun Zhang, Wencai Guan, Weifang Ren, Yujuan Liu, Guoxiong Xu
A Negative Feedback Loop Between NAMPT and TGF-β Signaling Pathway in Colorectal Cancer Cells. OncoTargets and therapy 14 (2021)
Fangran Liu, Jiao Liu, Jinguo Zhang, Jimin Shi, Lu Gui, Guoxiong Xu
Expression of STAT1 is positively correlated with PD-L1 in human ovarian cancer. Cancer biology & therapy 21 (10) (2020)
Jinguo Zhang, Fanchen Wang, Fangran Liu, Guoxiong Xu
Predicting STAT1 as a prognostic marker in patients with solid cancer. Therapeutic advances in medical oncology 12 (2020)
Jie Zhang, Huan Fang, Jinguo Zhang, Wencai Guan, Guoxiong Xu
Garcinol Alone and in Combination With Cisplatin Affect Cellular Behavior and PI3K/AKT Protein Phosphorylation in Human Ovarian Cancer Cells. Dose-response : a publication of International Hormesis Society 18 (2) (2020)

Guoxiong Xu.css-eqlu8i{font-size:small;padding-left:4px;} (Lingyun Zhang)

Publication Activity (10 Years)

Top Topics

Top Venues

Guoxiong Xu (Lingyun Zhang)